- Home
- BMRN vs FSLR Comparison
BMRN vs FSLR Comparison
Compare BMRN & FSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- FSLR
- Stock Information
- Founded
- BMRN 1996
- FSLR 1999
- Country
- BMRN United States
- FSLR United States
- Employees
- BMRN N/A
- FSLR N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- FSLR Semiconductors
- Sector
- BMRN Health Care
- FSLR Technology
- Exchange
- BMRN Nasdaq
- FSLR Nasdaq
- Market Cap
- BMRN 12.1B
- FSLR 13.1B
- IPO Year
- BMRN 1999
- FSLR 2006
- Fundamental
- Price
- BMRN $58.07
- FSLR $158.08
- Analyst Decision
- BMRN Buy
- FSLR Strong Buy
- Analyst Count
- BMRN 22
- FSLR 30
- Target Price
- BMRN $93.43
- FSLR $232.68
- AVG Volume (30 Days)
- BMRN 2.2M
- FSLR 6.0M
- Earning Date
- BMRN 05-01-2025
- FSLR 07-29-2025
- Dividend Yield
- BMRN N/A
- FSLR N/A
- EPS Growth
- BMRN 152.82
- FSLR 23.43
- EPS
- BMRN 2.71
- FSLR 11.77
- Revenue
- BMRN $2,950,227,000.00
- FSLR $4,256,749,000.00
- Revenue This Year
- BMRN $12.27
- FSLR $21.82
- Revenue Next Year
- BMRN $10.08
- FSLR $19.16
- P/E Ratio
- BMRN $21.47
- FSLR $13.43
- Revenue Growth
- BMRN 19.36
- FSLR 19.42
- 52 Week Low
- BMRN $52.93
- FSLR $116.56
- 52 Week High
- BMRN $94.85
- FSLR $306.77
- Technical
- Relative Strength Index (RSI)
- BMRN 41.32
- FSLR 53.73
- Support Level
- BMRN $57.27
- FSLR $153.77
- Resistance Level
- BMRN $59.12
- FSLR $161.62
- Average True Range (ATR)
- BMRN 1.40
- FSLR 9.52
- MACD
- BMRN 0.06
- FSLR -1.90
- Stochastic Oscillator
- BMRN 18.34
- FSLR 27.55
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.